Michael D. Wallis
Software Engineer at RGP
Michael D. Wallis, MS, is a software engineer at RGP. Previously, he was a developer and former analytical consultant in Artificial Intelligence and Machine Learning, Research and Development at SAS. Michael has been active in software development for nearly two decades, with the most recent 9 years focusing on NLP and text analytics. He holds a master's degree in computer science, with a focus in NLP, and was a member of the IntelliMedia research group, where he researched intelligent tutorial systems for modeling dialogue act tag sequencing.
By This Author
SAS® Text Analytics for Business Applications: Concept Rules for Information Extraction Models
By Teresa Jade, Biljana Belamarić Wilsey, and Michael D. Wallis
Information extraction is the task of automatically extracting structured information from unstructured or semi-structured text. SAS® Text Analytics for Business Applications: Concept Rules for Information Extraction Models focuses on this key element of natural language processing and provides real-world guidance on the effective application of text analytics.
Featured Authors
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.